Insiders · Profile

DesRosier Thomas

See Remarks at Seres Therapeutics. Filing since 26 Jan 2018. CIK 0001435744

Company
Date
Role
Action
Shares
Amount
Of holding
17 Aug 2026
See Remarks
Sold on a plan
82
$373.10
1.0%
18 May 2026
See Remarks
Sold on a plan
79
$594.87
1.0%
15 Feb 2026
See Remarks
Sold on a plan
78
$660.66
1.0%
15 Nov 2025
See Remarks
Sold on a plan
76
$1.31K
1.0%
18 Aug 2025
See Remarks
Sold on a plan
76
$1.27K
1.0%
15 May 2025
Chief Legal Officer and EVP
Sold on a plan
79
$575.12
1.1%
18 Feb 2025
Chief Legal Officer and EVP
Sold on a plan
4,300
$3.49K
2.9%
18 Nov 2024
Chief Legal Officer and EVP
Sold on a plan
878
$474.73
0.6%
28 Oct 2024
Chief Legal Officer and EVP
Sold on a plan
4,259
$2.94K
3.1%
16 Aug 2024
Chief Legal Officer and EVP
Sold on a plan
873
$733.32
0.7%
15 May 2024
Chief Legal Officer and EVP
Sold on a plan
843
$792.42
0.7%
16 Feb 2024
Chief Legal Officer and EVP
Sold on a plan
3,939
$4.25K
3.2%
30 Oct 2023
Chief Legal Officer and EVP
Sold on a plan
4,156
$5.61K
3.5%
28 Jan 2019
Chief Legal Officer and EVP
Sold, plan not stated
5,471
$31.48K
25.4%
26 Jan 2018
See Remarks
Sold, plan not stated
3,475
$38.29K
34.8%
15 decisions on file.